Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Myovant Sciences Ltd. (MYOV)

11.71   -0.07 (-0.59%) 02-14 16:02
Open: 11.75 Pre. Close: 11.78
High: 12 Low: 11.16
Volume: 821,372 Market Cap: 1051M
Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.018 - 12.102 12.102 - 12.166
Low: 10.951 - 11.059 11.059 - 11.142
Close: 11.554 - 11.707 11.707 - 11.824

Technical analysis

as of: 2020-02-14 4:30:57 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 15.70     One year: 17.34
Support: Support1: 11.16    Support2: 9.29
Resistance: Resistance1: 13.44    Resistance2: 14.85
Pivot: 12.63
Moving Average: MA(5): 12.38     MA(20): 12.85
MA(100): 10.86     MA(250): 12.43
MACD: MACD(12,26): -0.50     Signal(9): -0.42
Stochastic oscillator: %K(14,3): 10.95     %D(3): 19.16
RSI: RSI(14): 34.76
52-week: High: 26.02  Low: 4.14  Change(%): -44.9
Average Vol(K): 3-Month: 281465  10-Days: 100862

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
MYOV has closed above bottom band by 1.3%. Bollinger Bands are 56.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to MYOV's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Stock To Watch: Myovant Sciences (MYOV)
Myovant Sciences' (MYOV) phase III LIBERTY extension study of once-daily Relugolix combination therapy in women with uterine fibroids has yielded encouraging results.

Myovant Sciences Confirms Closing of US$400 Million Loan Facility
Myovant confirmed the closing of the previously announced loan facility from Sumitomo Dainippon Pharma, now increased to US$400 million. The post Myovant Sciences Confirms Closing of US$400 Million Loan Facility appeared first on Investing News Network .

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 89.68
Shares Float (M) 32.76
% Held by Insiders 56.55
% Held by Institutions 41.55
Shares Short (K) 2860
Shares Short P. Month (K)

Stock Financials

EPS -3.750
Book Value (p.s.) 0.190
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -97.0
Return on Equity (ttm) -622.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -3.037
Qtrly Earnings Growth
Operating Cash Flow (M) -250.36
Levered Free Cash Flow (M) -151.08

Stock Valuations

P/E -3.12
P/E Growth Ratio -0.01
P/BV 61.63
P/CF -4.19

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.